Key Insights

Highlights

Treatment Research

1 treatments under study, led by Petiveria Alliacea Preparation

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05587088Phase 1/2Unknown

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

Showing all 1 trials

Research Network

Common Treatments

  • Petiveria Alliacea Preparation1

Active Sponsors

  • Pontificia Universidad Javeriana1
  • Hospital Universitario San Ignacio1

Related Conditions

  • Acute Leukemia1
  • Colorectal Neoplasms1
  • Neoplasm Stomach1
  • Pancreatic Neoplasms1
  • Acute Leukemia In Relapse1

Activity Timeline